vs

Side-by-side financial comparison of Edwards Lifesciences (EW) and Loews Corporation (L). Click either name above to swap in a different company.

Edwards Lifesciences is the larger business by last-quarter revenue ($1.6B vs $827.0M, roughly 2.0× Loews Corporation). Loews Corporation runs the higher net margin — 48.6% vs 23.1%, a 25.5% gap on every dollar of revenue. On growth, Edwards Lifesciences posted the faster year-over-year revenue change (16.7% vs 4.8%). Over the past eight quarters, Edwards Lifesciences's revenue compounded faster (9.7% CAGR vs 7.9%).

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter.

Loews Corporation is a diversified US-based conglomerate that operates across multiple key industry segments through its subsidiaries. Its core business lines include property and casualty insurance, natural gas pipeline transportation, hospitality services, and upstream oil and gas exploration and production, primarily serving commercial, consumer and industrial clients across North American markets.

EW vs L — Head-to-Head

Bigger by revenue
EW
EW
2.0× larger
EW
$1.6B
$827.0M
L
Growing faster (revenue YoY)
EW
EW
+11.9% gap
EW
16.7%
4.8%
L
Higher net margin
L
L
25.5% more per $
L
48.6%
23.1%
EW
Faster 2-yr revenue CAGR
EW
EW
Annualised
EW
9.7%
7.9%
L

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
EW
EW
L
L
Revenue
$1.6B
$827.0M
Net Profit
$380.7M
$402.0M
Gross Margin
78.0%
Operating Margin
1.8%
65.4%
Net Margin
23.1%
48.6%
Revenue YoY
16.7%
4.8%
Net Profit YoY
6.8%
115.0%
EPS (diluted)
$0.66
$1.93

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EW
EW
L
L
Q1 26
$1.6B
Q4 25
$1.6B
$827.0M
Q3 25
$1.6B
$732.0M
Q2 25
$1.5B
$769.0M
Q1 25
$1.4B
$846.0M
Q4 24
$1.4B
$789.0M
Q3 24
$1.4B
$683.0M
Q2 24
$1.4B
$711.0M
Net Profit
EW
EW
L
L
Q1 26
$380.7M
Q4 25
$91.2M
$402.0M
Q3 25
$291.1M
$504.0M
Q2 25
$333.2M
$391.0M
Q1 25
$358.0M
$370.0M
Q4 24
$385.6M
$187.0M
Q3 24
$3.1B
$401.0M
Q2 24
$366.3M
$369.0M
Gross Margin
EW
EW
L
L
Q1 26
78.0%
Q4 25
78.1%
Q3 25
77.8%
Q2 25
77.5%
Q1 25
78.7%
Q4 24
78.9%
Q3 24
80.6%
Q2 24
79.9%
Operating Margin
EW
EW
L
L
Q1 26
1.8%
Q4 25
9.6%
65.4%
Q3 25
19.8%
94.1%
Q2 25
26.8%
70.1%
Q1 25
27.9%
60.8%
Q4 24
22.6%
23.8%
Q3 24
25.9%
80.5%
Q2 24
26.8%
71.3%
Net Margin
EW
EW
L
L
Q1 26
23.1%
Q4 25
5.8%
48.6%
Q3 25
18.7%
68.9%
Q2 25
21.7%
50.8%
Q1 25
25.3%
43.7%
Q4 24
27.8%
23.7%
Q3 24
226.7%
58.7%
Q2 24
26.7%
51.9%
EPS (diluted)
EW
EW
L
L
Q1 26
$0.66
Q4 25
$0.16
$1.93
Q3 25
$0.50
$2.43
Q2 25
$0.56
$1.87
Q1 25
$0.61
$1.74
Q4 24
$0.65
$0.87
Q3 24
$5.13
$1.82
Q2 24
$0.61
$1.67

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EW
EW
L
L
Cash + ST InvestmentsLiquidity on hand
$6.0B
Total DebtLower is stronger
$8.4B
Stockholders' EquityBook value
$18.7B
Total Assets
$86.3B
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EW
EW
L
L
Q1 26
Q4 25
$4.2B
$6.0B
Q3 25
$3.8B
$5.4B
Q2 25
$4.1B
$4.5B
Q1 25
$3.9B
$4.4B
Q4 24
$4.0B
$4.6B
Q3 24
$4.4B
$5.2B
Q2 24
$2.0B
$4.9B
Total Debt
EW
EW
L
L
Q1 26
Q4 25
$8.4B
Q3 25
$8.4B
Q2 25
$7.9B
Q1 25
$8.4B
Q4 24
$8.9B
Q3 24
$8.8B
Q2 24
$8.6B
Stockholders' Equity
EW
EW
L
L
Q1 26
Q4 25
$10.3B
$18.7B
Q3 25
$10.2B
$18.3B
Q2 25
$10.5B
$17.5B
Q1 25
$10.1B
$17.2B
Q4 24
$10.0B
$17.1B
Q3 24
$9.5B
$17.4B
Q2 24
$7.4B
$16.4B
Total Assets
EW
EW
L
L
Q1 26
Q4 25
$13.7B
$86.3B
Q3 25
$13.3B
$85.9B
Q2 25
$13.5B
$84.7B
Q1 25
$13.0B
$83.1B
Q4 24
$13.1B
$81.9B
Q3 24
$13.0B
$83.6B
Q2 24
$10.1B
$81.1B
Debt / Equity
EW
EW
L
L
Q1 26
Q4 25
0.45×
Q3 25
0.46×
Q2 25
0.45×
Q1 25
0.49×
Q4 24
0.52×
Q3 24
0.51×
Q2 24
0.52×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EW
EW
L
L
Operating Cash FlowLast quarter
$617.0M
Free Cash FlowOCF − Capex
$426.0M
FCF MarginFCF / Revenue
51.5%
Capex IntensityCapex / Revenue
23.1%
Cash ConversionOCF / Net Profit
1.53×
TTM Free Cash FlowTrailing 4 quarters
$2.7B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EW
EW
L
L
Q1 26
Q4 25
$450.9M
$617.0M
Q3 25
$573.7M
$920.0M
Q2 25
$290.2M
$1.0B
Q1 25
$280.4M
$736.0M
Q4 24
$-127.5M
$941.0M
Q3 24
$351.8M
$934.0M
Q2 24
$371.5M
$952.0M
Free Cash Flow
EW
EW
L
L
Q1 26
Q4 25
$353.5M
$426.0M
Q3 25
$516.2M
$764.0M
Q2 25
$240.9M
$872.0M
Q1 25
$224.4M
$638.0M
Q4 24
$-177.3M
$767.0M
Q3 24
$299.9M
$794.0M
Q2 24
$286.1M
$793.0M
FCF Margin
EW
EW
L
L
Q1 26
Q4 25
22.5%
51.5%
Q3 25
33.2%
104.4%
Q2 25
15.7%
113.4%
Q1 25
15.9%
75.4%
Q4 24
-12.8%
97.2%
Q3 24
22.1%
116.3%
Q2 24
20.9%
111.5%
Capex Intensity
EW
EW
L
L
Q1 26
Q4 25
6.2%
23.1%
Q3 25
3.7%
21.3%
Q2 25
3.2%
17.4%
Q1 25
4.0%
11.6%
Q4 24
3.6%
22.1%
Q3 24
3.8%
20.5%
Q2 24
6.2%
22.4%
Cash Conversion
EW
EW
L
L
Q1 26
Q4 25
4.94×
1.53×
Q3 25
1.97×
1.83×
Q2 25
0.87×
2.57×
Q1 25
0.78×
1.99×
Q4 24
-0.33×
5.03×
Q3 24
0.11×
2.33×
Q2 24
1.01×
2.58×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EW
EW

Segment breakdown not available.

L
L

Transportation And Storage Of Natural Gas And NG Ls And Ethane Supply And Transportation Services$601.0M73%
Lodging And Related Services$226.0M27%

Related Comparisons